INTRODUCTION
============

The human brain is a very intricate system and several factors such as age and various diseases may affect its working \[[@B1]\]. Diabetes mellitus (DM) is a metabolic disease that can have worsening effects on many organs, including the brain. It adversely affects the central nervous system leading to cognitive impairments \[[@B2][@B3]\]. Although both diabetes types play a crucial role in memory weakening, their mode of action on memory and learning system remains unclear \[[@B4]\]. It is reported that factors such as improved apoptosis, reduced neuronal densities, metabolic impairments, and oxidative stress are crucial in the pathogenesis of cognitive impairment and memory deficiency \[[@B5]\]. Several studies recommended a significant role of oxidative stress in the pathogenesis of cognitive impairment \[[@B6]\]. The long-term hyperglycemia enhances glucose oxidation, which sequentially produces reactive oxygen species (ROS) causing increased oxidative stress; this leads to morphological and functional changes in the hippocampus due to the excessive production of malanoldehyde (MDA) and reduced efficacy of superoxide dismutase (SOD) \[[@B7]\]. Moreover, several evidences reported that dietary enrichment with nutritional antioxidants could improve the cognitive function not only in normal subjects but also in cognitive deficits after stroke \[[@B8][@B9][@B10][@B11]\].

Although many antioxidants are available, we used a natural approach to suppress the oxidative stress in the brain. Cinnamon (*Cinnamomum cassia*) is widely used for centuries as a natural spice and flavoring material throughout the world \[[@B12]\]. In some countries, it is used in traditional medicine as an antidiabetic agent. Cinnamon contains volatile oils such as cinnamaldehyde, eugenol, and cinnamic acid; phenolic compounds such as tannin, catechins, and proanthocyanidin; mono terpenes and sesquiterpenes; and trace coumarin \[[@B12][@B13][@B14]\]. Among these compounds, cinnamic acid and cinnamaldehyde form the major components of cinnamon aqueous extract. Moreover, it has been reported that in rats, cinnamaldehyde is partly metabolized into cinnamic acid in the stomach and small intestine, and is almost completely metabolized into cinnamic acid in the liver before it is absorbed into the blood \[[@B15]\]. Cinnamic acid moderates glycogenesis and gluconeogenesis and decreased blood glucose and glucose tolerance in diabetic rats \[[@B16]\]. Additionally, cinnamic acid increases the insulin secretion in isolated islets \[[@B12]\]. Furthermore, several studies have reported other pharmacological properties of cinnamic acid, including hepatoprotective \[[@B17]\] and antioxidant activity \[[@B18][@B19][@B20]\]. Cinnamic acid reveals high antioxidant activity due to the presence of vinyl fragments. This property develops our interest in studying this compound as a potential drug for the management of pathologies associated with the lipid peroxidation in cellular membranes \[[@B21]\]. The present study was designed to determine the therapeutic effect of cinnamic acid on memory impairment in diabetic mice, in addition to reducing the previously observed diabetic symptoms. Therefore, we planned to examine the therapeutic effect of cinnamic acid on memory and cognitive impairment, oxidative stress, and cholinergic dysfunction in streptozotocin (STZ)-induced model of diabetes in male mice.

METHODS
=======

Chemicals and drugs
-------------------

Cinnamic acid (99% pure), 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), mannitol, ethylene glycol tetra acetic acid (EGTA), bovine serum albumin (BSA), 2,7-di chloro fluorescein diacetate (DCFH-DA), 3,4 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), Rhodamine 123, thiobarbituric acid, trichloroacetic acid, 1,1,3,3-tetramethoxypropane, reduced glutathione, oxidized glutathione, Coomassie Brilliant Blue and STZ powder were purchased from Sigma-Aldrich (St Louis, Missouri, USA), and sucrose 5, 5′-dithiobis-2-nitrobenzoic acid (DTNB), dimethyl sulfoxide (DMSO), NaCl, KCl, CaCl~2~, MgCl~2~ and NaHCO~3~ were obtained from Merck company (Darmstadt, Germany).

Animals
-------

48 males Naval Medical Research Institute (NMRI) mice (30--35 g) were obtained from the animal facility of Ahvaz Jundishapur University of Medical Science (AJUMS), which is completely qualified by AJUMS animal care guidelines with an ethics committee grantee No. IR.AJUMS.REC.1396.261. After one week adaptation, the mice were housed eight per cage in polycarbonate cages with corncob bedding in 20±4℃ temperature with a 12 h light/12 h dark cycle and 10% humidity.

Induction and assessment of diabetes
------------------------------------

Animals were rendered diabetic by a single intraperitoneal STZ injection of 50 mg/kg. STZ was dissolved in 0.05 M citrate buffer at pH 4.5, immediately before administration. The control mice (n=8) were injected with citrate buffer alone. Blood glucose levels were evaluated using a glucometer (ACON Laboratories, Inc., USA) 72 h later. The mice with glucose levels higher than 220 mg/dl were considered as diabetic. Accordingly, the animals exposed to chronic hyperglycemia revealed obvious pathological changes in the central nerve structure and function, three weeks after STZ injection; the blood glucose level was again determined and mice with final blood glucose levels above 220 mg/dl were considered diabetic \[[@B22]\].

The mice used in this study were randomly assigned into six groups:

\(1\) Control group (Con) (n=8); normal mice treated with saline, IP (physiological saline 0.1 ml/100 g), for 40 days(2) Cinnamic group (cinn) (n=8); normal mice treated with cinnamic (20 mg/kg/day), for 40 days(3) Control diabetic group (DM) (n=8); diabetic mice treated with saline, IP (physiological saline 0.1 ml/100 g), for 40 days(4) DM+ cinnamic group1 (n=8); diabetic mice treated with cinnamic (10 mg/kg/day), for 40 days.(5) DM+ cinnamic group2 (n=8); diabetic mice treated with cinnamic (20 mg/kg/day), for 40 days(6) DM+ cinnamic group1 (n=8); diabetic mice treated with cinnamic (40 mg/kg/day), for 40 days

Behavioral training
-------------------

### Passive avoidance test

The step-down passive avoidance task is used to evaluate the state-dependent learning and memory. The apparatus consisted of a box made of Plexiglas with dimensions of 40×30×30 cm with a floor of steel bars. Each of the steel bars was 4 mm. in diameter with a spacing of 13 mm. A wooden platform with dimensions of 4×4×4 cm at the bottom center of the floor was provided. Electric shocks with a frequency of 1 Hz at 15 V for 15 s using a stimulator connected to the floor bars transmitted a shock to the animals\' hands and feet. When the animal was placed on the podium, the natural tendency of the animal was to get down on the floor bars; however, if the animal received a shock its innate desire to get down from on the platform was suppressed, in particular, an inhibitory avoidance learning occurred. The latency time of moving down from the safe podium (stepdown latency) was considered as memory retrieval \[[@B23]\], which involved two stages, namely training and testing. In the training phase, animals were slowly placed on the wooden platform in the middle of the device and the delay in moving down from the platform was recorded by a chronometer. When the mouse stepped down from the platform and placed all its paws on the grid floor, intermittent electric shocks were delivered continuously for 15 s. Before the final shock, the animal was removed \[[@B24][@B25]\]. This training procedure was performed between 9:00 and 15:00 h, and animals with latencies longer than 30 s were omitted from the study. The test phase was conducted for 24 h after the training phase and was similar to the training phase; however, in this phase the animal did not receive any shock treatment. Thus, each animal was slowly placed on the wooden platform again and the delay in coming down from the platform was considered as a memory retrieval. In these experiments, the time limit for retaining the mouse on the podium was of maximum 300 s \[[@B23]\]. The retention test was also conducted between 9:00 and 15:00 h. At the end of each test, the surface of the apparatus was thoroughly cleaned to avoid the presence of olfactory cues \[[@B25]\].

### Spatial navigation memory test

This test was performed using cross-arm maze. The task was to test the navigation memory, which could be weakened by brain damage. This model was used to test the spatial navigation memory considering the spatial orientation and perception as described by Ragozzino et al. \[[@B26]\]. The maze was constructed of wood, painted gray, and comprised a central platform (25 cm diameter), which radiated four symmetrical arms (55 cm long×10 cm wide) with 12 cm walls. Briefly, mice were placed individually in a four-arm cross maze and were allowed to transverse the maze freely for 12 min. The number and arrangement of entries were noted; an alternation was defined as an entry into four different arms on an overlapping quadruple set. Four consecutive arm choices within the total set of arm choices made up a quadruple set. A quadruple set consisting of arm choices B, D, C, A comprised "actual alternation," whereas the set with B, D, B, A did not (using this procedure, possible alternation sequences were equal to the number of total arm entries minus three). Percent alternation was calculated as follows: $$Alternation~\% = \frac{Actual~alternation \times 100}{Possible~alternation*}$$$$*Number~of~total~arm~entries~ - ~3.$$

Alternation percentage is an indicator of spatial navigation memory of the experimental mice and the number of total arm entries is the index of the locomotor activity in this maze \[[@B22]\].

### Morris water maze test

The device comprised a round container, 100 cm in diameter and 50 cm in depth. The tank was filled with water (21--26℃) up to a height of 30 cm and the transparent escape platform made of Plexiglas (10 cm in diameter and 29 cm in height) was concealed at 1.5 cm under the surface of water at a fixed place. The water was turned milky with powdered nonfat milk or nontoxic white colored dye. The platform was not observable from just above the water level and removal trials have designated that escape on to the platform was not done by visual or other proximal signs \[[@B27][@B28]\]. The period spent by the animal to reach the concealed platform was used as the memory index. Before the test commencement, the mice were adapted to the maze location. The water maze test was conducted for all mice groups on 10th, 20th, 30th, and 40th days for all animals (n=5). For each trial, the time required (in seconds) for an individual mouse to find the concealed platform was recorded and the mean data from the tests were used for the statistical analyses.

Biochemical analysis
--------------------

### Determination of brain weight to body weight ratio

At the end of 40 days, the mice were decapitated under ether anesthesia. The skull was cut open and the brain was exposed from its dorsal side. The whole brain was quickly removed and weighed. Then the ratio of brain weight to body weight was calculated for each animal \[[@B29]\].

### Brain tissue preparation

The whole brain was quickly removed and cleaned with normal saline on the ice. A 10% (w/v) homogenate of brain samples (0.03 M sodium phosphate buffer, pH-7.4) was prepared by using an Ultra-Turrax T25 (USA) homogenizer at a speed of 9500 rpm. The homogenized tissue preparation was used to measure AChE, ROS, Catalase, MDA, GSH and nitrite.

### Reactive oxygen species (ROS) level in tissues of brain

The level of ROS in brain tissue was measured using 2, 7-dichlorofluorescindiacetate (DCFDA) that converted into highly fluorescent DCF by cellular peroxides. Briefly, 10% brain homogenate were prepared in phosphate buffer 1 mM, pH 7.4. For each test 2 ml homogenate tissue was mixed with 40 ml of 1.25 mM DCFDA in methanol for ROS estimation. All samples were incubated for 15 min in a water bath at 37℃. Fluorescence was calculated using a fluorimeter, at 488 nm excitation and 525 nm emission wavelength \[[@B30]\].

### Glutathione (GSH) in tissue of brain

Glutathione content was measured according to the method described by Thomas and Skrinska. Brain homogenates were incubated whit 1 ml of 20% trichloroacetic acid (TCA) and 1 ml EDTA 1mM for 5 min, which was used as protein precipitant. The total homogenate was centrifuged at 10,000 g for 30 min at 4℃. 200 µl of supernatant was mixed with 1.8 ml of 0.1 mM 5.5′-dithio-bis (2-nitro benzoic acid) (DTNB). The GSH reacts with DTNB and forms a yellow-colored complex with DTNB. The absorbance was read at 412 nm. The result was expressed as µmoles of GSH/mg protein \[[@B31]\].

### Thiobarbituric acid reactive substances (TBARS) in tissue of brain

The extent of lipid peroxidation in terms of malondialdehyde (MDA) formation was measured. Briefly homogenate brain sample containing 1 ml was mixed with 1 ml TCA (20%), 2 ml TBA (0.67%) and heated for 1 h in boiling water bath. After cooling, mixture centrifuged and absorbance of the supernatant measured at 532 nm against suitable blank. The amount of TBARS was calculated by using a molar extinction coefficient of ε=1.56×10^5^/M/cm and expressed as mol/mg protein \[[@B31]\].

### Catalase (CAT) in tissue of brain

Catalase activity was assayed according to the method used by L.Goth. 500 µl of 0.05 mmol Tris-HCl, 1 ml H~2~O~2~ and 50 µl of sample were mixed and incubated for 10 min, and then Reaction was stopped by adding 500 µl Ammonium molybdate solution 4%. The absorbance was read at 410 nm. The result was expressed as U/mg protein \[[@B32]\].

### Superoxide dismutase (SOD) in tissue of brain

The SOD activity was determined using a xanthine/xanthine oxidase system for production of superoxide radical and subsequent measurement of cytochrome c as a scavenger of the radicals. Optical density was evaluated using a spectrometer (UV-1601, Shimadzu) at 550 nm. One unit of enzyme activity was defined as the quantity of SOD required to inhibit the reduction rate of cytochrome *c* by 50% \[[@B33]\]. SOD activity is presented as units per milligram of protein (U/mg protein).

### Estimation of brain total protein

Total brain protein was estimated by the Lowry et al method using bovine serum albumin (BSA) (1 mg/ml) as standard. The absorption was read spectrophotometrically at 750 nm \[[@B34]\].

### Nitrite estimation

Nitrite was estimated using Greiss reagent, which served as an indicator of nitric oxide production. An amount of 100 µL Greiss reagent (1:1 solution of 1% sulphanilamide in 5% phosphoric acid and 0.1% napthaylamine diamine dihydrochloric acid in water) was added to 100 µL of supernatant and absorbance was measured at 542 nm \[[@B35]\]. Nitrite concentration was calculated using a standard curve for sodium nitrite. Nitrite levels were expressed as of the control percentage.

### Estimation of brain acetyl cholinesterase (AChE) activity

The whole brain AChE activity was measured by the Ellman method \[[@B36]\] and Voss and Sachsse method \[[@B37]\]. Change in the absorbance per min of the sample was read spectrophotometrically at 420 nm.

### Blood glucose and serum insulin estimation

Twenty four hours after the last experimental day, the overnight fasting animals were anesthetized by ether. Fasting blood glucose levels (FBG) were measured using a glucometer (Elegance CT-X10, Convergent Technologies, Germany) by cutting the tail tip of mice. Furthermore, blood samples were directly collected by cardiac puncture and centrifuged at 3500 rpm for 20 min. Insulin level was measured by ELISA assay kits (Monobind, USA) (The sensitivity of hormone detection per assay tube was 0.182 µIU/ml).

Statistical analysis
--------------------

Data were expressed as means±SE for three different experiments. All the results were analyzed using Graph Pad Prism (version 5.04). Statistical significance was determined using the oneway analysis of variance (ANOVA) with the Tukey\'s post hoc test. Statistical significance was set at p\<0.05.

RESULTS
=======

Effects of diabetes and cinnamic acid on state-dependent memory
---------------------------------------------------------------

Step-down passive avoidance task assesses the ability of the animals to retain and recall information. The mean initial latency did not significantly differ among the various groups, whereas the retention latency significantly differed between the groups. [Fig. 1A-D](#F1){ref-type="fig"} represents comparisons of step-down latency in different groups before treatment and after 20 and 40 days. The results revealed that the step-down latency significantly decreased in diabetic mice as compared to the controls after 20 (p\<0.05) and 40 (p\<0.01) days. Treatment of the diabetic mice with cinnamic acid caused significant (p\<0.01, p\<0.001) increase in the step-down latency compared to the diabetic group after 40 days. Cinnamic acid alone did not cause any significant change in the retention latency in the passive avoidance test before 20 days; however, the retention latency increased compared to control group (p\<0.05) after 40 days ([Fig. 1](#F1){ref-type="fig"}).

Effect of diabetes and cinnamic acid on spatial navigation memory
-----------------------------------------------------------------

[Fig. 2](#F2){ref-type="fig"} represents the number of arm entries, as the locomotor activity index in cross-arm maze significantly (p\<0.05) decreased in diabetic mice as compared to the controls. Treatment of diabetic mice with cinnamic acid significantly (p\<0.05) increased the locomotor activity in dose-dependent manner compared to the diabetic group. No significant increase was observed in the number of arm entries in mice injected with cinnamic acid alone when compared to the control animals.

[Fig. 3](#F3){ref-type="fig"} reveals the percent alternation in the cross-arm maze. Diabetes significantly decreased the actual alternation score, thereby decreasing the alternation percentage and the spatial navigation memory index in the cross-arm maze compared to the control group (p\<0.01), whereas administration of cinnamic acid significantly (p\<0.01) and in dose-dependent manner prevented the spatial memory debilitation in diabetic mice. Moreover, cinnamic acid injection significantly (p\<0.05) increased the alternation percentage in intact animals compared to the control animals.

Effect of diabetes and cinnamic acid on spatial memory in morris water maze test
--------------------------------------------------------------------------------

Our results on spatial memory abilities in mice revealed that, compared to the control mice, escape latency (time taken to reach the hidden platform) decreased from 130 to 80 s in cinnamic acid-treated mice, whereas in mice injected with STZ, the escape latency increased from 180 to 250 s throughout the total tenure of the test. One interesting observation on group IV mice treated with STZ and concurrently administered with cinnamic acid was that, even though the escape latency was more (170 s) than that of the control mice at the initial stages, after 40 days, it almost reached the normal levels (130 s) ([Fig. 4](#F4){ref-type="fig"}).

Effect of diabetics and cinnamic acid on oxidative stress in STZ treated mice
-----------------------------------------------------------------------------

### Effects on ROS formation in the brain tissue

Increased ROS formation is expressed as DCF fluorescence intensity unit. As mentioned in [Table 1](#T1){ref-type="table"}, ROS level was significantly (p\<0.001) elevated in the brain of diabetic animals as compared to the control. Cinnamic acid administration significantly (p\<0.001) inhibited the ROS production in diabetic mice. Moreover, exposure to cinnamic acid resulted in significantly (p\<0.05) lower ROS formation in nondiabetic mice when compared with the control ([Table 1](#T1){ref-type="table"}).

### Effect on glutathione (GSH) level in the brain tissue

Glutathione assessment results reported a significant decrease in the diabetic group compared to the control mice (p\<0.001). Cinnamic acid administration significantly (p\<0.01) prevented this decrease in GSH level in diabetic mice. Moreover, exposure to cinnamic acid resulted in significantly (p\<0.05) greater GSH level in nondiabetic mice when compared with the control mice (p\<0.05) ([Table 1](#T1){ref-type="table"}).

### Effects on thiobarbituric acid reactive substances (TBARS) in the brain tissue

The results of lipid peroxidation revealed that STZ treated group reported significant increase in the MDA level (p\<0.001) in comparison to the control group. Cinnamic acid administration significantly (p\<0.01) inhibited the MDA level in diabetic mice. No significant difference was observed between cinnamic acid-treated mice and control group ([Table 1](#T1){ref-type="table"}).

### Effects on catalase enzyme level in the brain tissue

Assessment of brain homogenates indicated a significant (p\<0.01) decrease in the CAT activities in diabetic group than the control animals, while cinnamic acid administration significantly (p\<0.01) ameliorated these indices in diabetic mice. No significant difference was observed between the cinnamic acid-treated mice and the control group ([Table 1](#T1){ref-type="table"}).

### Effect on SOD activity in the brain tissue

As shown in [Table 1](#T1){ref-type="table"}, the SOD production was significantly reduced in brains of the STZ treated mice (p\<0.001). Administration of cinnamic acid significantly increased the SOD activity in the brain, when compared with the STZ-treated group (p\<0.01).

Effect of cinnamic acid on STZ induced nitrosative stress
---------------------------------------------------------

Nitrite levels were significantly (p\<0.05) elevated in the brain of STZ treated animals as compared to the control group. Cinnamic acid administration significantly (p\<0.05) inhibited the nitrite levels in STZ treated mice ([Fig. 5](#F5){ref-type="fig"}).

Effect of cinnamic acid on STZ induced changes in acetylcholinesterase activity
-------------------------------------------------------------------------------

Acetylcholinesterase (AChE) activity significantly (p\<0.01) increased in STZ treated mice when compared with the control group. Cinnamic acid significantly (p\<0.05) inhibited AChE activity in STZ treated mice ([Fig. 6](#F6){ref-type="fig"}).

Effect of f diabetics and cinnamic acid on body weight, brain weight to body weight ratio, final blood glucose and serum insulin
--------------------------------------------------------------------------------------------------------------------------------

As anticipated, diabetic mice weighed less than the control group (p\<0.01). Furthermore, administration of cinnamic acid (40 mg/kg) in diabetic mice revealed a significant increase in weight than the diabetic control mice (p\<0.05) ([Table 2](#T2){ref-type="table"}).

The average total brain to body weight ratio after 40 days training was significantly greater in diabetic mice than the control mice (p\<0.01); however, no significant difference was observed between the cinnamic acid-treated diabetic mice and the diabetic control group ([Table 2](#T2){ref-type="table"}).

The results revealed that STZ treated group reported a significant increase in the FBG level (p\<0.001) in comparison to the control group. Cinnamic acid administration significantly (p\<0.01) inhibited the FBG level in diabetic mice. No significant difference was observed between the cinnamic acid-treated mice and the control group ([Table 2](#T2){ref-type="table"}).

As shown in [Table 2](#T2){ref-type="table"}, the insulin level was significantly reduced in the serum of the STZ treated mice (p\<0.05). No significant difference was observed in the serum insulin level (mg/dl) among the STZ and cinnamic acid-treated STZ groups (10, 20 and 40 mg/kg).

DISCUSSION
==========

The present study examined the effects of cinnamic acid treatment on memory impairment, oxidative stress, and cholinergic dysfunction in STZ-induced model of diabetes in mice. Previous studies have suggested that diabetes mellitus is connected with neurological difficulties in the central nervous system \[[@B38][@B39][@B40]\] such as weak learning and memory \[[@B41][@B42][@B43]\]. Based on the concentration, STZ can contribute to type 1 and type 2 diabetes. In this study, not only does the diabetes type matter but also a model of diabetes that can cause defects in memory is equally important. Previous study suggested that the STZ mice model is an applicable animal model used for studying the memory impairment \[[@B44][@B45][@B46][@B47]\]. STZ is a glucosamine-nitrosourea compound, which was known as an antibiotic. It is toxic to the beta cells of pancreas and was generally used to induce experimental diabetes in animals. STZ administration through the intracebroventricular or intraperitoneal route produces reduced cognition and increased cerebral aggregated Aβ fragments, total tau protein, and Aβ deposits \[[@B48]\]. Administering STZ in a rodent\'s brain is known to cause neuroinflammation, oxidative stress, and biochemical alterations, which is considered to be a valid experimental model for the early pathophysiological changes in the neurodegenerative diseases \[[@B49]\]. Furthermore, the STZ treated animals develop insulin resistant brains, which are associated with memory impairment, progressive cholinergic deficits, glucose hypometabolism, oxidative stress, and neurodegeneration that share many common features with dementia observed in humans \[[@B50]\]. Thus, from the aforementioned reports, it is inferred that STZ produces most prevalent type of memory impairment. In the present study, administration of STZ in mice showed a persistent memory deficit in passive avoidance test as evidenced by significantly reduced in step-down latencies and in Morris water maze test as proved by increased in escape latency.

Cognitive and memory deficits in diabetes mellitus can result from hyperglycemia \[[@B51][@B52]\]. Although the pathogenesis of these deficits is multifactorial, sufficient data is available for excess production of reactive oxygen species (ROS) \[[@B37][@B51]\]. STZ caused oxidative stress by significantly increasing the MDA level and decreasing the GSH level. Furthermore, the nitrite levels in brain of STZ treated mice significantly increased. This increase in the oxidative stress may be due to hyperglycemic disorder prevalent in brain after administration of STZ. The brain slices of STZ rats are known to display reduced glucose ingestion as compared to the control rats, leading to hyperglycemic condition in the brain \[[@B52]\]. Plaschke et al. \[[@B53]\] indicated increased extracellular concentration of glucose in the brain of STZ injected rats. This may lead to improved glucose auto-oxidation, resulting in production of advanced glycation end-products. In addition, improved free radicals, due to greater oxidative stress, increased the nitrite level. Hyperglycemia induces upregulation of iNOS and parallel increase of superoxide formation leads to the production of peroxynitrite, a potent pro-oxidant, which exaggerates the oxidative stress \[[@B54][@B55][@B56][@B57][@B58][@B59]\].

In the present study, administration of STZ significantly increased the malondialdehyde levels, an index of lipid peroxidation, in the brain. One reason for the raised lipid peroxidation in STZ-induced diabetes is the decrease of antioxidant enzymes such as glutathione peroxidase and catalase activities. In this experiment, we found that untreated diabetes initiated reduced function of glutathione peroxidase and catalase in the brain. Our findings are consistent with the previous reports, which suggest that the antioxidant enzyme functions decreased in the brain during chronic diabetic neuropathy \[[@B39][@B60][@B61]\]

In diabetic animal models, such as those induced by STZ, reduced synaptic plasticity and impaired performances on behavioral learning tasks, are common \[[@B61][@B62][@B63][@B64][@B65]\], and a reduction in diabetic animals performance has been shown in complex task, such as Morris water maze and T-maze \[[@B66][@B67][@B68]\].

In the present study, treatment by cinnamic acid, in STZ injected mice, improved spatial memory and condition avoidance memory. In passive avoidance test, administration of cinnamic acid for 40 days after STZ-induced memory deficit, reported memory improvement; however, the vehicle treated group exhibited memory impairment even after 20 days. Moreover, in this study we have examined the effects of cinnamic acid on spatial navigation memory in diabetic mice by cross-arm maze. We reported that diabetes could significantly decrease the actual alternation percent as a spatial navigation memory index; however, oxidative stress may contribute to spatial navigation deficit during hyperglycemia. Therefore, antioxidants could be preferred to prevent the memory damage associated with diabetes. Herein, we found that cinnamic acid as an antioxidant could increase the alternation percent during the cross-maze test. We observed that the number of arm entries, as a locomotors activity index, in cross-arm maze, decreased in diabetic mice. Treatment with cinnamic acid increased the locomotor activity and the alternation percent in diabetic mice; whereas, cinnamic acid increased the alternation percent but did not alter the locomotor activity in nondiabetic mice. This contradiction indicates that increasing effect of cinnamic acid on actual alternation score could not be a result from the locomotors activity in crescent in diabetics. Furthermore, the results of the Morris water maze test also confirm the effect of cinnamic acid on enhancing the spatial memory in diabetic and nondiabetic mice.

This memory enhancement by cinnamic acid has been attributed to its act as an effective antioxidant that results from its direct free radicals scavenging activity and inducing antioxidant enzymes \[[@B69]\]. In our study, the treatment of diabetic animals with cinnamic acid significantly decreased the lipid peroxidation in the brain. Furthermore, we demonstrated an increase in the glutathione peroxidase, SOD, and catalase activities in the brain by administering the cinnamic acid; sufficient evidence identifies cinnamic acid as a potent antioxidant \[[@B18][@B70]\]. Our results also indicated a decrease in ROS and nitrite level in cinnamic acidtreated mice. The reduction in nitrite level by cinnamic acid may be due to its effect on the inducible nitric oxide synthase (iNOS) expression and downregulation of its expression in the brain.

Beside oxidative stress, there is decreased activity of glycolytic enzymes in the STZ model of memory deficit mice resulting in decreased acetylcholine level \[[@B53][@B71][@B72]\], which is associated with cognition. Acetylcholine is metabolized by the enzyme acetyl cholinesterase (AChE); hence, AChE inhibitors are the most effective pharmacological resources for the treatment of cognition impairment \[[@B73]\]. In the present study, we reported increased AChE activity in the brain of STZ treated mice. This result is in accordance with the previous studies displaying rise in the AChE expression \[[@B74]\] and activity after STZ injection \[[@B47][@B75][@B76]\]. Additionally, it is reported that the activity of AChE increased in the cerebral cortex of STZ-induced diabetic rats \[[@B37][@B77]\]. Therefore, the modifications in AChE action may be a result of hyperglycemia like situation in the brain produced by STZ administration \[[@B78]\]. The restoration of AChE activity by cinnamic acid may be due to the enhancement of disturbed glucose metabolism and insulin signaling induced by STZ \[[@B78]\].

CONCLUSION
==========

In conclusion, the present study reported that cinnamic acid treatment in diabetic mice revealed memory enhancement, which may be a result of its effective antioxidant activity. Hence, the use of cinnamic acid as a nutritional supplement should be encouraged to prevent diabetes and age associated memory disorders.
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Letter a: indicates significant difference compared to control group (p\<0.05). Letter b: indicates significant difference compared to diabetic group (p\<0.05). p values were from oneway ANOVA, followed by Tukey\'s test for multiple comparisons.](kjpp-22-257-g002){#F2}
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###### Effect of diabetics and cinnamic acid on oxidative stress in STZ treated mice
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Data are Mean±SD; n=8. MDA, Malondialdehyde; ROS, reactive oxygen species; GSH, glutathione; SOD, superoxide dismutase. ^a^Significantly different from control group (p\<0.05), ^b^Significantly different from diabetic group (p\<0.05), a^\*^ and b^\*^: p\<0.01, a^\*\*^ and b^\*\*^: p\<0.001, p values were from one-way ANOVA, followed by Tukey\'s test for multiple comparisons.

###### Effect of diabetes and cinnamic acid on body weight, brain weight to body weight ratio, final blood glucose and serum insulin
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Data are Mean±SD; n=8. ^a^Significantly different from control group (p\<0.05), ^b^Significantly different from diabetic group (p\<0.05), a^\*^ and b^\*^: p\<0.01, a^\*\*^ and b^\*\*^: p\<0.001, p values were from one-way ANOVA, followed by Tukey\'s test for multiple comparisons.
